Marksans Pharma Share Price Today | Stock Price & Marksans Pharma Share Screener

Track the current stock price of Marksans Pharma with an interactive chart. Analyse MARKSANS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Marksans Pharma stock quote in one place.

The quote of ₹331.65 sits between the 52-week low of ₹156.89 and the 52-week high of ₹347.60, and the latest session moved 1.86% from the previous close.

Screen Marksans Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MARKSANS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE750C01026.

Classification

Identifiers and Leadership

Screen MARKSANS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,861, up from ₹3,240 in 2025.

Latest statistics put total assets at ₹3,861 and shareholder funds at ₹3,053, with a leverage ratio of 0.12.

Screen Marksans Pharma income statement and profit fundamentals. Analyze MARKSANS quarterly results. Marksans Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹866 and net profit was ₹159, equal to earnings per unit of ₹3.47, at an operating margin of 25%.

In that period expenses were ₹628, interest cost ₹7 and tax ₹47. The next period listed, 2026-Mar, shows revenue of ₹891 and net profit of ₹149.

Screen MARKSANS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹458, and net cash flow was an inflow of ₹138.

Over the same period, investing activities used ₹249 and financing activities used ₹71.

See Marksans Pharma shareholding pattern with promoter, FII, and DII holdings. Check Marksans Pharma promoter holding and ownership changes for MARKSANS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 43.87%, foreign institutions 16.76%, domestic institutions 6.57% and the public 28.33%, spread across 246,279 shareholders.

The shareholder count was 246,279 in 2026-Mar, compared with 246,635 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Marksans Pharma. Marksans Pharma dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.90 per unit for 2026-March, a yield of 0.28%, compared with ₹0.80 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.90, ₹0.80 and ₹0.60 per unit.

See which indices include Marksans Pharma stock. Check MARKSANS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Get Marksans Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Marksans Pharma stock events that may affect MARKSANS share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 27, 2026, with a record date of August 27, 2026.

It is followed by Dividend dated August 20, 2026 and Quarterly Result Announcement dated August 12, 2026.

Screen MARKSANS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen MARKSANS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 27, 2026.

The next most recent announcements are dated September 17, 2026 and September 7, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.